ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Selvita to Present New Data from SEL120 Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
November 10, 2018The presentation during the symposium will feature preclinical data from Selvita’s CDK8 inhibitor program SEL120 - potential treatment of acute myeloid and lymphoblastic leukemias. SEL120 is the most advanced, fully-owned oncology program in company’s pip -
International symposium on Drafting a National Policy of Medicinal and Aromatic Plants of India inau
January 20, 2017More than 300 prominent members of medicinal and aromatic plants community are expected to attend the conference
Pharma Sources Insight January 2025
